|
IQVIA™ Real-World Insights Bibliography
| Treatment cost of acute coronary syndrome with ticagrelor compared to clopidogrel in Switzerland. |
| Author(s): Gasche D1, Ulle T2, Meier B3, Greiner RA1 |
| Affiliations(s): 1 IMS Health, Munich, Germany 2 AstraZeneca AG, Zug, Switzerland 3 Department of Cardiology, Bern University Hospital, Bern, Switzerland |
Publication(s): Gemeinsamen Jahrestagung der Schweizerischen Gesellschaften für Kardiologie und der Schweizerischen Gesellschaft für Herz- und Thorakale Gefässchirurgie - in press, 2013.
|
| Document Type(s): Poster, |
| Countries: Switzerland, |
C:
Y: |
Cardiovascular disease,
2013 |
|
L:
A: |
English
Cost analysis, |
|
 |
| |
| |
| Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden. |
| Author(s): Valentine WJ1, Aagren M2, Haglund M3-4, Ericsson A3, Gschwend MH5 |
| Affiliations(s): 1Ossian Health Economics and Communication, Basel, Switzerland, 2Novo Nordisk Inc., Princeton, NJ, USA, 3Novo Nordisk Scandinavia AB, Malmo, Sweden, 4NeuroSearch A/S, Ballerup, Denmark and 5IMS Health, Basel, Switzerland |
Publication(s): Scandinavian journal of public health
|
| Document Type(s): Manuscript in preparation, |
| Countries: Nordic, Switzerland, |
| Click here for the abstract |
C:
Y: |
Diabetes,
2011 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Cost-effectiveness of Roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland |
| Author(s): Samyshkin Y1, Radford M1, Schlunegger M2, Gooss A2
|
| Affiliations(s): 1IMS Health, London, UK, 2Nycomed Pharma AG, Dübendorf, Switzerland |
Publication(s): ISPOR 14th Annual European Conference, 5-8 November 2011, Madrid, Spain
|
| Document Type(s): Poster, |
| Countries: Switzerland, |
| Click here for the abstract |
C:
Y: |
Respiratory disease,
2011 |
|
L:
A: |
English
Cost effectiveness, |
|
|
| |
| |
| Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. |
| Author(s): Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7,
Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10,
Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2 |
| Affiliations(s): 1
Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2
CIBER of
Epidemiology and Public Health, Madrid, Spain; 3
Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4
Department of Epidemiology, Johns Hopkins Bloomberg School
of Public Health, Baltimore, MD 21205, USA; 5
Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6
Welch Center for
Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7
Department of Cardiovascular Epidemiology and
Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8
Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN,
UK; 9
Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003
Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium |
Publication(s): Eur Heart J. 2011 Sep;32(17):2143-52
|
| Document Type(s): Article, |
| Countries: Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease,
2011 |
|
L:
A: |
English
Observational study, Prospective study, |
|
|
| |
| |
| Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. |
| Author(s): Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F. |
| Affiliations(s): |
Publication(s): BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.
|
| Document Type(s): Article, |
| Countries: Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease,
2011 |
|
L:
A: |
English
Observational study, Prospective study, |
|
|
| |
| |
| Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland. |
| Author(s): Foppa I, Karmaus W, Ehlken B, Fruhwirth M, Heiniger U, Plenge-Bonig A, Forster J. |
| Affiliations(s): |
Publication(s): Infect Control Hosp Epidemiol. 2006; 27(6): 633-5.
|
| Document Type(s): Article, |
| Countries: Austria, Germany, Switzerland, |
C:
Y: |
Infectious disease,
2006 |
|
L:
A: |
English
Epidemiological study, |
|
|
| |
| |
 3 of 3
|
|
